252 related articles for article (PubMed ID: 16686599)
1. Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay.
Blangy A; Bouquier N; Gauthier-Rouvière C; Schmidt S; Debant A; Leonetti JP; Fort P
Biol Cell; 2006 Sep; 98(9):511-22. PubMed ID: 16686599
[TBL] [Abstract][Full Text] [Related]
2. The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin.
Bellanger JM; Astier C; Sardet C; Ohta Y; Stossel TP; Debant A
Nat Cell Biol; 2000 Dec; 2(12):888-92. PubMed ID: 11146652
[TBL] [Abstract][Full Text] [Related]
3. [Role of the multifunctional Trio protein in the control of the Rac1 and RhoA gtpase signaling pathways].
Bellanger JM; Zugasti O; Lazaro JB; Diriong S; Lamb N; Sardet C; Debant A
C R Seances Soc Biol Fil; 1998; 192(2):367-74. PubMed ID: 9759378
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant.
Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y
J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635
[TBL] [Abstract][Full Text] [Related]
5. Identification of the first Rho-GEF inhibitor, TRIPalpha, which targets the RhoA-specific GEF domain of Trio.
Schmidt S; Diriong S; Méry J; Fabbrizio E; Debant A
FEBS Lett; 2002 Jul; 523(1-3):35-42. PubMed ID: 12123800
[TBL] [Abstract][Full Text] [Related]
6. The Human Rho-GEF trio and its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth.
Estrach S; Schmidt S; Diriong S; Penna A; Blangy A; Fort P; Debant A
Curr Biol; 2002 Feb; 12(4):307-12. PubMed ID: 11864571
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Dbl and dock-family RhoGEFs: a yeast-based assay to identify cell-active inhibitors of Rho-controlled pathways.
Blangy A; Fort P
Enzymes; 2013; 33 Pt A():169-91. PubMed ID: 25033805
[TBL] [Abstract][Full Text] [Related]
8. Different regulation of the Trio Dbl-Homology domains by their associated PH domains.
Bellanger JM; Estrach S; Schmidt S; Briançon-Marjollet A; Zugasti O; Fromont S; Debant A
Biol Cell; 2003 Dec; 95(9):625-34. PubMed ID: 14720465
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel neuronal isoforms of the Rho-GEF Trio.
Portales-Casamar E; Briançon-Marjollet A; Fromont S; Triboulet R; Debant A
Biol Cell; 2006 Mar; 98(3):183-93. PubMed ID: 16033331
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-derived peptides as potent inhibitors of the oncogenic RhoGEF Tgat.
Bouquier N; Fromont S; Zeeh JC; Auziol C; Larrousse P; Robert B; Zeghouf M; Cherfils J; Debant A; Schmidt S
Chem Biol; 2009 Apr; 16(4):391-400. PubMed ID: 19389625
[TBL] [Abstract][Full Text] [Related]
11. The two guanine nucleotide exchange factor domains of Trio link the Rac1 and the RhoA pathways in vivo.
Bellanger JM; Lazaro JB; Diriong S; Fernandez A; Lamb N; Debant A
Oncogene; 1998 Jan; 16(2):147-52. PubMed ID: 9464532
[TBL] [Abstract][Full Text] [Related]
12. The guanine nucleotide exchange factor trio mediates axonal development in the Drosophila embryo.
Bateman J; Shu H; Van Vactor D
Neuron; 2000 Apr; 26(1):93-106. PubMed ID: 10798395
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
Wang L; Zhu K; Zheng Y
Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
[TBL] [Abstract][Full Text] [Related]
14. The DH and PH domains of Trio coordinately engage Rho GTPases for their efficient activation.
Chhatriwala MK; Betts L; Worthylake DK; Sondek J
J Mol Biol; 2007 May; 368(5):1307-20. PubMed ID: 17391702
[TBL] [Abstract][Full Text] [Related]
15. A cell active chemical GEF inhibitor selectively targets the Trio/RhoG/Rac1 signaling pathway.
Bouquier N; Vignal E; Charrasse S; Weill M; Schmidt S; Léonetti JP; Blangy A; Fort P
Chem Biol; 2009 Jun; 16(6):657-66. PubMed ID: 19549603
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the activation of small GTPases by their GEFs on membranes using artificial membrane tethering.
Peurois F; Veyron S; Ferrandez Y; Ladid I; Benabdi S; Zeghouf M; Peyroche G; Cherfils J
Biochem J; 2017 Mar; 474(7):1259-1272. PubMed ID: 28196833
[TBL] [Abstract][Full Text] [Related]
17. Trio GEF mediates RhoA activation downstream of Slit2 and coordinates telencephalic wiring.
Backer S; Lokmane L; Landragin C; Deck M; Garel S; Bloch-Gallego E
Development; 2018 Oct; 145(19):. PubMed ID: 30177526
[TBL] [Abstract][Full Text] [Related]
18. Opposite Modulation of RAC1 by Mutations in TRIO Is Associated with Distinct, Domain-Specific Neurodevelopmental Disorders.
Barbosa S; Greville-Heygate S; Bonnet M; Godwin A; Fagotto-Kaufmann C; Kajava AV; Laouteouet D; Mawby R; Wai HA; Dingemans AJM; Hehir-Kwa J; Willems M; Capri Y; Mehta SG; Cox H; Goudie D; Vansenne F; Turnpenny P; Vincent M; Cogné B; Lesca G; Hertecant J; Rodriguez D; Keren B; Burglen L; Gérard M; Putoux A; ; Cantagrel V; Siquier-Pernet K; Rio M; Banka S; Sarkar A; Steeves M; Parker M; Clement E; Moutton S; Tran Mau-Them F; Piton A; de Vries BBA; Guille M; Debant A; Schmidt S; Baralle D
Am J Hum Genet; 2020 Mar; 106(3):338-355. PubMed ID: 32109419
[TBL] [Abstract][Full Text] [Related]
19. Prepatterning by RhoGEFs governs Rho GTPase spatiotemporal dynamics during wound repair.
Nakamura M; Verboon JM; Parkhurst SM
J Cell Biol; 2017 Dec; 216(12):3959-3969. PubMed ID: 28923977
[TBL] [Abstract][Full Text] [Related]
20. Phagocytosis of apoptotic cells is regulated by a UNC-73/TRIO-MIG-2/RhoG signaling module and armadillo repeats of CED-12/ELMO.
deBakker CD; Haney LB; Kinchen JM; Grimsley C; Lu M; Klingele D; Hsu PK; Chou BK; Cheng LC; Blangy A; Sondek J; Hengartner MO; Wu YC; Ravichandran KS
Curr Biol; 2004 Dec; 14(24):2208-16. PubMed ID: 15620647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
